Journals / Türk Onkoloji Dergisi / 2008 / Cilt: 23 - Sayı: 3

The role of dose volume histograms and TGF-β in the prediction of radiation pneumonitis: a pilot study

Radyasyon pnömonisinin öngörülmesinde doz volüm histogramları ve TGF-β'nın yeri: Pilot çalışma

Pages
109–119
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Dose parameters of ipsi- and contralateral lungs revealed that higher MLD, V20, V30 values in contralateral lung were statistically significant for pneumonitis (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:OBJECTIVES To evaluate the role of some parameters of dose volume histograms (DVH) and plasma TGF-β levels in predicting radiation pneumonitis in non-small cell lung cancer (NSCLC) patients.
📊
Key Findings & Data:METHODS Fifteen NSCLC patients treated with 3D conformal radiotherapy were included in the study.
💡
Conclusion & Impact:Dose parameters of ipsi- and contralateral lungs revealed that higher MLD, V20, V30 values in contralateral lung were statistically significant for pneumonitis (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

OBJECTIVES To evaluate the role of some parameters of dose volume histograms (DVH) and plasma TGF-β levels in predicting radiation pneumonitis in non-small cell lung cancer (NSCLC) patients. METHODS Fifteen NSCLC patients treated with 3D conformal radiotherapy were included in the study. Radiotherapy dose was a median 60 Gy. Mean lung dose (MLD), V20 and V30 were calculated from both ipsilateral and contralateral lung DVH. TGF-β levels were studied with ELISA.RESULTS Median follow-up was 16 months (range 10-55). Radiation pneumonitis was diagnosed in three patients (6, 9, 12 months). Dose parameters of ipsi- and contralateral lungs revealed that higher MLD, V20, V30 values in contralateral lung were statistically significant for pneumonitis (p

Özet

AMAÇ Torasik radyoterapi uygulanan küçük hücreli olmayan akciğer kanserli (KHOAK) hastalarda, radyasyon pnömonisi riski ile doz volüm histogramları (DVH) parametreleri ve plazma T G F -βseviyelerinin korelasyonu araştırıldı. GEREÇ VE YÖNTEM Bu çalışmaya üç boyutlu konformal radyoterapi uygulanan 15 KHOAK hastası dahil edildi. Radyoterapi dozu 50-66 Gy arası nda değişmekte olup, medyan doz 60 Gy idi. Olguların tümünde ipsilateral ve kontrlateral akciğerler için DVH’larından elde edilen MLD, V20, V30 değerleri incelendi. TGF-β seviyeleri ELISA yöntemi ile değerlendirildi.BULGULAR Olguların medyan takip süresi 16 ay idi (aralık 6-55). Bu süre içerisinde radyasyon pnömonisi üç olguda saptandı (1.,6. ve 9. aylarda). İpsilateral ve kontrlateral akciğerlerin doz par am e tr el eri karşılaştırıldığında, kontrlateral akciğ erlerin MLD, V20 ve V30 değerlerinin yüksek oluşu pnömoni gelişimi açısından anlamlı bulundu (p

🔖

Cite This Article

UZUN, H., AYDIN, S., KOCA, S., ATALAR, B., DİNÇBAŞ, F. Ö. (2022). The role of dose volume histograms and TGF-β in the prediction of radiation pneumonitis: a pilot study. Türk Onkoloji Dergisi, Cilt: 23 - Sayı: 3, 109–119. https://ajindex.com/articles/639356

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics, 1997. CA Cancer J Clin 1997;47(1):5-27
  2. Murphy TP, Casey MT. Determination of operability in candidates who undergo lung resection for bronchogenic carcinoma. Can J Surg 1990;33(6):470-3
  3. Perez C, Azarnia N, Cox J. Sequela of definitive irradiation in the treatment of carcinoma of the lung. In: Motta G, editor. Lung cancer: advanced concepts and present status. Genoa, Italy: G Motta Publishing; 1989
  4. Emami B, Graham MV. Lung. In: Perez CA, Brady LW, editors. Principles and practice of radiation oncology. Philadelphia, New York: Lippincott-Raven; 1998. p. 1181-220
  5. Armstrong JG, Burman C, Leibel S, Fontenla D, Kutcher G, Zelefsky M, et al. Three-dimensional conformal radiation therapy may improve the therapeutic ratio of high dose radiation therapy for lung cancer. Int J Radiat Oncol Biol Phys 1993;26(4):685-9
  6. Martel MK, Ten Haken RK, Hazuka MB, Turrisi AT, Fraass BA, Lichter AS. Dose volume histogram and 3-D treatment planning evaluation of patients with pneumonitis. Int J Radiat Oncol Biol Phys 1994;28(3):575-81
  7. Langer M, Kijewski P. CCRT (computer controlled radiation therapy) for non small cell lung cancer: sensitivity of clinical gains to organ tolerance restrictions. Int J Radiat Oncol Biol Phys 1992;22(2):325-32
  8. Marks LB, Munley MT, Bentel GC, Zhou SM, Hollis D, Scarfone C, et al. Physical and biological predictors of changes in whole-lung function following thoracic irradiation. Int J Radiat Oncol Biol Phys 1997;39(3):563-70
  9. Rubin P, Johnston CJ, Williams JP, McDonald S, Finkelstein JN. A perpetual cascade of cytokines postirradiation leads to pulmonary fibrosis. Int J Radiat Oncol Biol Phys 1995;33(1):99-109
  10. Franklin TJ. Therapeutic approaches to organ fibrosis. Int J Biochem Cell Biol 1997;29(1):79-89
  11. Grande JP. Role of transforming growth factor-beta in tissue injury and repair. Proc Soc Exp Biol Med 1997;214(1):27-40
  12. Anscher MS, Kong FM, Jirtle RL. The relevance of transforming growth factor beta 1 in pulmonary injury after radiation therapy. Lung Cancer 1998;19(2):109-20
  13. Rodemann HP, Bamberg M. Cellular basis of radiationinduced fibrosis. Radiother Oncol 1995;35(2):83-90
  14. Hakenjos L, Bamberg M, Rodemann HP. TGF-beta1-mediated alterations of rat lung fibroblast differentiation resulting in the radiation-induced fibrotic phenotype. Int J Radiat Biol 2000;76(4):503-9
  15. Martin M, Lefaix J, Delanian S. TGF-beta1 and radiation fibrosis: